New Technologies: Deborah Performs Delaware Valley’s First Cryoplasty Procedure for Peripheral Vascular Disease
Are You Interested in Being Contacted for an Appointment?
Building for the Future
World's Most Advanced Cardiac CT Scanner
QuickOpt
Radial Artery Harvesting
Minimally Invasive Direct Coronary Artery Bypass (MIDCAB)
Minimally Invasive Mitral and Aortic Valve Replacement
Transmyocardial Revascularization (TMR)
Cryoplasty
Drug-Eluting Stents
Chest Aneurysm Repair
Silverhawk

It’s no secret that heart disease is the nation’s number one killer, affecting 12 million Americans. As many as 60 percent of these patients will also suffer from vascular disease, or blockages in the arteries of the legs, arms, neck or abdomen.

For many patients with vascular disease in the legs, even walking one city block is sometimes impossible. The pain in the legs and feet associated with vascular disease is often unbearable; the patient must stop and rest to relieve the pain, which returns upon resumption of exercise. These patients often are prescribed exercise to improve cardiac health, and are unable to follow those orders, resulting in poorer cardiac outcome.

Many interventional and surgical procedures used to clear blockages in the coronary arteries are used in the peripheral arteries as well, including balloon angioplasty. To perform this procedure, a cardiologist inserts a catheter into the patient’s groin, threads the catheter up the femoral artery to the coronary blockage, and inserts a wire with a tiny balloon attached into the catheter. Once the wire crosses the blockage, the tiny balloon fills with saline solution and inflates inside the artery. The blockage is compressed against the vessel wall, the vessel opens, and blood flow is restored to the heart. Often, a stainless steel mesh tube, called a stent, is inserted to help “prop” the artery open.

Despite its success in the coronary arteries, this procedure does not always offer long-term success in the legs, especially in the femoral artery in the thigh. For reasons still unknown to physicians, this artery is prone to renarrowing after interventional procedures to open it – as many as 60 percent of patients will experience reoccurring blockages. Stents, which could help support the artery walls, are not a desirable option in this artery because scar tissue is highly likely to form within the stent, causing further blockages. Bypass surgery is costly and invasive, and grafts to this artery are prone to occlusion themselves. Often, vascular disease patients have no option for bypass surgery because the saphenous vein (the vein most desirable to use for leg bypass) has been used previously to bypass the coronaries.

For these reasons, Cryoplasty shows extraordinary promise for vascular disease patients. Boasting long-term success rates never before seen in the femoral artery, this procedure’s clinical trials showed less than 15 percent reocclusion nine months post-procedure. The procedure is nearly identical to standard balloon angioplasty; a catheter is inserted, a wire is guided through the catheter and across the blockage, and a balloon is inflated, compressing the blockage and dilating the vessel. However, during Cryoplasty, the balloon is inflated using nitrous oxide, which cools the vessel (in the immediate area of the balloon) to –10 degrees Celsius. This cooling causes apoptosis, or controlled cell death; that cell death prevents cells from multiplying in this area and causing recurring blockages in the artery. It also prevents the artery walls from renarrowing.

According to Manu Rajachandran, MD, Chair, Department of Endovascular Medicine, Deborah Heart and Lung Center, Cryoplasty is the future of vascular disease treatment.

“This procedure represents remarkable promise and significant hope for vascular disease patients, as we’re now able to offer them long-term relief for their leg pain without bypass surgery,” Dr. Rajachandran said. “Cryoplasty, though currently only FDA-approved for use in the legs, may offer the same relief and results in the coronary arteries, renal arteries, carotid arteries, and more, and could be used to treat all of these conditions in the future.

Deborah Heart and Lung Center is proud to be the first center in the Delaware Valley to offer this landmark treatment, as it represents Deborah’s desire to remain on the cutting edge, offering the most comprehensive, up-to-date treatment options for our patients.

Return to Home l Cardiac Services l Pulmonary Services l Patient Information l Support Groups l Directions

Are You Interested in Being Contacted for an Appointment?
Questions? send your e-mail to
askaquestion@deborah.org